Professor Margaret Gardner became President and Vice-Chancellor of Monash University on 1 September 2014. 

Prior to joining Monash, Professor Gardner was Vice-Chancellor and President of RMIT from April 2005 until August 2014. She has extensive academic experience, having held various leadership positions in Australian universities throughout her career, including at the University of Queensland and Griffith University. 

Professor Gardner is Chair of the Group of Eight Universities. She is also a Director of Infrastructure Victoria and the Australia and New Zealand School of Government (ANZSOG). 

In November 2019, Professor Gardner was appointed chair of CASE Asia-Pacific Regional Council.

Before founding Focus IP Group, LLC, an intellectual property consulting company in 2011, Dr. Stevens was Director of the technology transfer office at Boston University for seventeen years, following four years in a similar role at the Dana-Farber Cancer Institute, a teaching affiliate of the Harvard Medical School.  He helped create over 60 spin-out companies from these two institutions, a number of which raised substantial amounts of venture capital.

Dr. Stevens works extensively as an Expert Witness in patent infringement cases, in which his role is to determine the reasonable royalty that the parties would have agreed to in a hypothetical negotiation on the eve of infringement.  In the course of this work, he has reviewed and analyzed hundreds of license agreements covering a broad range of pharmaceutical, biopharmaceutical, diagnostic and biotechnology technologies. He has valued individual technologies for use in licensing and pre-litigation settlement discussions for a spectrum of clients in both the public and private sectors.

Dr. Chris Bumby is Chief Scientist (Materials) at the Robinson Research Institute within Victoria University of Wellington, New Zealand. The Robinson Institute has active R&D programmes developing a range of forefront engineering technologies, including superconducting magnets, electric aircraft and space thrusters, in partnership with global corporates and investors. At present, Dr. Bumby leads the New Zealand Government’s R&D programme on hydrogen steelmaking, which targets the future commercial production of zero-CO₂ steel in New Zealand. He has 20 years experience working in elite R&D environments in the UK, Europe and NZ, and has authored 7 patents and more than 100 peer-reviewed scientific articles. He has delivered commercial R&D solutions to a wide range of stakeholders, including international corporates, start-ups, and government agencies. Dr. Bumby is a former member of the NZ Climate Change Commission’s Technical Advisory Panel for Heat, Industry and Power, and currently sits on the Royal Society of New Zealand’s Marsden Panel for Physics, Chemistry and Biochemistry.

Dr Tim Boyle is Director, Innovation & Commercialisation and ANSTO and Founder of the nandin Innovation Centre, ANSTO’s centre for commercialisation, design innovation and entrepreneurship. Tim is an internationally recognised leader in research translation and IP commercialisation with over 20 years’ experience developing the interface between research and business. In adding to his role at ANSTO, Tim has many Director and Advisory roles, most notably as a Director of KCA and Chair of the Alliance of Technology Transfer Professionals, the global association of national associations representing the research commercialisation profession.

Dr Bayode Ero-Phillips is an Industry Engagement Manager at Queensland University of Technology (QUT), where he translates QUT’s research/intellectual property (IP) into tangible outcomes.

Dr Ero-Phillips previously worked in research commercialisation at The University of Western Australia (UWA) where he led the spinning out of UWA’s technology for synthesising advanced lubricants into a start-up commercialising superlubricants. He was a Non-Executive Director and later Chief Commercialisation and Strategy Officer of the start-up.

Bayode is a Trade Marks Attorney, a Registered Technology Transfer Professional (RTTP) and a Certified Materials Professional (CMatP). He is also a Graduate of the Australian Institute of Company Directors (GAICD) and holds an MBA (Distinction) from UWA, a Graduate Diploma in IP Law from The University of Melbourne, a PhD in Metallurgy & Materials from The University of Birmingham as well as a B.Sc in Metallurgical & Materials Engineering (1^st Class) from Nigeria.

Additionally, he serves on the Board of Knowledge Commercialisation Australasia (KCA) and is also the Chair of the Conference Planning Committee.

Meredith leads the design and delivery of Climate-KIC's Systems Innovation framework in Australia. She is part of the Australian Industry Energy Transition Initiative implementation team, developing decarbonisation projects and collaborations. She leads work on portfolio design, implementation and sensemaking in areas including resilience and adaptation, agriculture, regional decarbonisation and innovation. 

Gabrielle Munzer is a principal at Main Sequence where she is deeply involved in a number of company creation opportunities including Samsara with ANU and Eden Brew. with CSIRO. With a strong focus on ESG principles, Gabrielle specifically seeks investments in startups with the ambition to have massive impact in the world.

Gabrielle brings more than 15 years of financial markets experience to Main Sequence, having worked  at Challenger in Australia and Morgan Stanley and ABN AMRO in London. 

Gabrielle earned her Bachelor of Science in International Securities, Investment and Banking from the University of Reading and received a Master of Business Administration from INSEAD. In between earning her Bachelor’s and MBA, she also completed a fellowship program for Leadership in Sustainable Development from LEAD.

Gabrielle is a mentor with the CSIRO-led ON Accelerator program which is focussing on universities with its recently announced government support.

Erin is a leader in commercialisation, passionate about creating impact with research and is currently the Executive Director, Industry Engagement at the Queensland University of Technology. Prior to joining QUT, Erin has led industry engagement and research development for several universities and has worked across Australia and the United Kingdom. She has a PhD in tissue engineering, is a Graduate of the Australian Institute of Company Directors, is a Registered Technology Transfer Professional and a Superstar of STEM. Erin contributes to the commercialisation policy discussion through her role as Director of Knowledge Commercialisation Australasia. She is also Chair of QUT Bluebox and a Director of CelluAir.

As Senior Business Initiatives Manager at University of Wollongong, Zahra leverages her extensive experience with NSW industry to identify areas of common strategic research between Industry and University focused on translational research and commercialisation. In 2020 she was awarded the prestigious title of RTTP.

Anita is Director, Business Development - Health & Biosecurity for CSIRO where is responsible for leading the business development and commercial impact strategy for CSIRO's Health and Biosecurity portfolio. 

Anita has a health and medical research translation background partnering with pharmaceutical and medtech companies and start-ups to commercialise their R&D. Prior to joining CSIRO, Anita worked for NSW Health to design and deliver world class clinical trial infrastructure to the public health system.